article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

article thumbnail

The new technologies strengthening pharmaceutical supply chains

Pharmaceutical Technology

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. The legacy of this disruption has been a rethink in the way pharma companies do business.

Big Data 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. He oversees operations, including business development, sales and marketing, and people. Web Sun is co-founder and president at Komodo Health. About the author.

article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

.” The partners stress that this novel approach, paired with the “explosion in availability and accessibility of real-world data and real-world evidence”, as Sun states, creates an opportunity to use this new technique to supplement the evidence traditionally generated from clinical trial control groups.

article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Big Data 130